Genprex, Inc. (GNPX)
1.90
-0.08
(-4.04%)
USD |
NASDAQ |
Oct 23, 10:28
Genprex Price to Book Value : 0.0650 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 0.0677 |
| October 21, 2026 | 0.0701 |
| October 20, 2026 | 0.0729 |
| October 19, 2026 | 0.0705 |
| October 16, 2026 | 0.0722 |
| October 15, 2026 | 0.0784 |
| October 14, 2026 | 0.0797 |
| October 13, 2026 | 0.0859 |
| October 12, 2026 | 0.092 |
| October 09, 2026 | 0.0931 |
| October 08, 2026 | 0.0941 |
| October 07, 2026 | 0.0896 |
| October 06, 2026 | 0.0893 |
| October 05, 2026 | 0.0931 |
| October 02, 2026 | 0.09 |
| October 01, 2026 | 0.0876 |
| September 30, 2026 | 0.0999 |
| September 29, 2026 | 0.0975 |
| September 28, 2026 | 0.0961 |
| September 25, 2026 | 0.1126 |
| September 24, 2026 | 0.1204 |
| September 23, 2026 | 0.1283 |
| September 22, 2026 | 0.1211 |
| September 21, 2026 | 0.1191 |
| September 18, 2026 | 0.118 |
| Date | Value |
|---|---|
| September 17, 2026 | 0.1184 |
| September 16, 2026 | 0.1167 |
| September 15, 2026 | 0.1132 |
| September 14, 2026 | 0.118 |
| September 11, 2026 | 0.1146 |
| September 10, 2026 | 0.1146 |
| September 09, 2026 | 0.1174 |
| September 08, 2026 | 0.1211 |
| September 04, 2026 | 0.1197 |
| September 03, 2026 | 0.1172 |
| September 02, 2026 | 0.1201 |
| September 01, 2026 | 0.1215 |
| August 31, 2026 | 0.1269 |
| August 28, 2026 | 0.1256 |
| August 27, 2026 | 0.1235 |
| August 26, 2026 | 0.1358 |
| August 25, 2026 | 0.1369 |
| August 24, 2026 | 0.1375 |
| August 21, 2026 | 0.1351 |
| August 20, 2026 | 0.1351 |
| August 19, 2026 | 0.1365 |
| August 18, 2026 | 0.1351 |
| August 17, 2026 | 0.1531 |
| August 14, 2026 | 0.1478 |
| August 13, 2026 | 0.1666 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.604 |
| Alnylam Pharmaceuticals, Inc. | 22.18 |
| Anika Therapeutics, Inc. | 2.056 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.887 |
Price to Book Value Related Metrics
| Price | 1.90 |
| Earnings Yield | -8.36K% |
| Market Cap | 0.9618M |